Mike Hennessy Jr.

This issue of CURE highlights personal stories and expert insights, from living with multiple diagnoses to self-advocacy, nutrition and survivorship care.

A significant development in the treatment of advanced melanoma has recently emerged: tumor-infiltrating lymphocyte (TIL) therapy.

A powerful new ally is emerging in cancer care: artificial intelligence.

The journey that led to the creation of the Extraordinary Healer Award for Oncology Nursing began with a simple, yet profound, observation.

New advancements in cancer treatment are reducing the need for radical surgeries, offering organ-sparing therapies and enhancing survivorship care and support for patients.

At CURE, we remain steadfastly dedicated to providing our readers with answers about cancer research.

In this Fall issue of CURE, we focus on AYAs with cancer, latest treatments in small cell lung cancer, preparing for a virtual visit and answering common questions about breast cancer.

Cancer-related fatigue is felt physically, mentally and emotionally, which can significantly affect one’s quality of life.

In the 2024 CURE Summer issue, we focused on a facet of cancer: the question of faith.

Within the genitourinary cancer space, there have been many treatment advances over the past year.

This year marks the 18th year that CURE and Oncology Nursing News have hosted the Extraordinary Healer Award for Oncology Nursing, which gives people the opportunity to recognize and honor the oncology nurses who have made a significant impact on their life.

In the Spring 2024 issue of CURE® Magazine, we also cover financial hardships caused by scammers who purposely target patients with cancer.

The CURE® 2024 Lung Cancer Special Issue provides insight into the ever-changing innovation in the lung cancer space.

In our issue of Heal Spring, we bring awareness to important topics, such as mental health after cancer treatment and how survivors can mend their minds.

This November, our country celebrates 76 years of Veteran’s Day, and we want to increase awareness of veterans with lung cancer in this special issue of CURE.

The Food and Drug Administration, in a flurry of activity, approved three new medications across a three-month period earlier this year.

As with many other areas in health care, some patients may face barriers when it comes to genetic services for breast cancer.

Mental and emotional well-being are crucial to a person’s overall health, and they deserve plenty of attention from patients and providers alike.

Because MPNs can cause chronic disease that spans years or even decades, some patients need their significant other to become their caregiver.

A new method of chemotherapy administration is being explored for certain solid cancers.

We need to learn more about how to potentially lessen toxins' effects on people's lives.

Going through cancer is a marathon, not a sprint.

From fertility issues to oral side effects, cancer survivors may face health complications after treatment ends.

It is essential that patients with breast cancer speak up to their health care providers, be it advocating for genetic testing or discussing symptoms.

Once seen as a malignancy resistant to typical treatments such as chemotherapy, metastatic kidney cancer has come a long way in the past 20 years.

From a rare malignancy to sexual dysfunction, this special issue explores some of the less talked about aspects of cancer.

For many cancer survivors, a dark cloud hangs over them after treatment ends, as they fear their disease coming back.